Provention Bio PRVB
$ 24.98
0.0%
Annual report 2022
added 03-29-2023
Provention Bio Financial Ratios 2011-2024 | PRVB
Annual Financial Ratios Provention Bio
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.7 | -3.1 | -9.0 | -14.9 | -1.9 | - | - | - | - | - | - | - |
P/S |
138.4 | 254.2 | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.5 | -1.8 | -1.9 | -1.1 | -1.2 | -1.0 | - | - | - | - | - | - |
EV (Enterprise Value) |
1.86 B | 301 M | 804 M | 610 M | -5.32 M | -19.6 M | 290 K | - | - | - | - | - |
EBITDA per Share |
-1.71 | -1.83 | -1.9 | -1.09 | -1.17 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.3 | -6.2 | -13.7 | 0.3 | - | - | - | - | - | - | - | |
PEG |
- | 0.06 | -1.36 | 0.01 | - | - | - | - | - | - | - | |
P/B |
14.7 | 3.2 | 8.0 | 7.9 | 0.9 | - | - | - | - | - | - | - |
P/CF |
-23.7 | -3.7 | -11.6 | -17.9 | -2.3 | - | - | - | - | - | - | - |
ROE % |
-93.20 | -103.34 | -88.75 | -52.69 | -44.38 | - | - | - | - | - | - | - |
ROA % |
-47.95 | -84.38 | -76.71 | -50.33 | -43.03 | - | - | - | - | - | - | - |
ROCE % |
-105.18 | -104.37 | -89.75 | -54.01 | -44.95 | - | - | - | - | - | - | - |
Current Ratio |
2.1 | 5.4 | 7.4 | 22.4 | 32.9 | - | - | - | - | - | - | - |
DSO |
19.2 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
19.2 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
19.2 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Provention Bio
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.34 | - | -0.35 | - | -0.43 | -0.46 | -0.52 | - | -0.56 | -0.45 | -0.26 | - | -0.24 | -0.32 | -0.29 | - | -0.17 | -1.05 | -0.52 | - | -0.15 | -0.44 | - | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.35 | - | -0.46 | - | -0.43 | -0.47 | -0.52 | - | -0.56 | -0.46 | -0.27 | - | -246 | -328 | -301 | - | -0.17 | -1.02 | -0.5 | - | -0.14 | -0.42 | - | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-66.42 | -86.57 | -63.62 | -82.06 | -56.23 | -84.41 | -92.45 | -93.92 | -59.42 | -71.32 | -55.03 | -49.72 | -39.86 | -48.90 | -46.04 | -48.76 | -34.86 | -12.28 | 19.33 | 103.68 | 189.59 | 289.59 | 267.01 | 100.00 | 100.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-50.64 | -67.76 | -52.17 | -68.07 | -48.19 | -72.54 | -79.78 | -81.10 | -51.36 | -62.72 | -49.72 | -46.47 | -38.08 | -46.84 | -44.24 | -47.09 | -33.80 | -39.87 | -37.18 | -38.40 | -24.10 | -24.10 | -18.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-81.82 | -102.01 | -71.25 | -90.34 | -56.94 | -85.22 | -93.30 | -94.73 | -60.38 | -72.52 | -56.38 | -50.78 | -40.76 | -49.83 | -46.77 | -48.89 | -34.55 | -11.76 | 20.10 | 103.23 | 188.88 | 288.88 | 266.09 | 100.00 | 100.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 4.0 | - | 4.3 | 5.5 | 6.6 | 7.2 | 7.2 | 7.4 | 7.4 | 7.4 | 7.4 | 22.4 | - | - | - | 32.9 | 49.9 | 20.6 | - | 9.8 | 9.8 | 9.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency